ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the launch of its enhanced Avantect® Pancrea...

Sygnature Discovery, a leading drug discovery contract research organisation (CRO), has today announced a strategic brand relaunch, including a new website, cementin...

Amorphical, a developer of nano-amorphous mineral-based pharmacologic agents, today announced that long-term data from its Phase 2 trial in moderate-to-severe Crohn’...

 Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, and Quotient Sciences, a leading global c...

Kayentis, a global provider of electronic Clinical Outcome Assessment (eCOA) and Decentralized Clinical Trial (DCT) solutions, and Ametris (formerly ActiGraph), a gl...

Slope and LabConnect have announced significant momentum in their partnership following the 2025 launch of an API integration that connects Slope’s site-facing platf...

Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of the CRF Creator module within its Pinnacle 21 Enterpr...

Cirena, pioneers in long and ultra-long, high purity RNA synthesis for gene editing and functional genomics, today announced its public launch following successful d...

Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the divestment of its...